Loading company…
SpeeDx is a Sydney molecular diagnostics company that develops multiplex qPCR assays for infectious disease research.
Founded in 2009 in Sydney, Australia, SpeeDx Pty. Ltd. sells Research Use Only assays for sexually transmitted infections, respiratory infections and antibiotic resistance markers, including its Plex Plus technology. Customers include clinical laboratories, academic institutions and research organizations. In its most recent fiscal year it reported revenue of USD 8,148,673.10 and EBITDA of USD 13,609,720. In February 2023 it raised USD 26.00 mn led by Northpond Ventures, Platinum Asset Management and Tenmile.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in